Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Insulin Aspart”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)UnknownNCT03244241
What this trial is testing

Basal-bolus Insulin Therapy Versus Standard Therapy for the Inpatient Management of Type 2 Diabetes: the IDA2 Study

Who this might be right for
Type 2 Diabetes Mellitus
Merete Bechmann Christensen 100
Early research (Phase 1)Study completedNCT03723759
What this trial is testing

A Research Study Looking at How Faster Aspart Injected in Double Concentration Works in the Body of People With Type 1 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 1
Novo Nordisk A/S 56
Post-approval studies (Phase 4)Study completedNCT00564395
What this trial is testing

Detemir: Role in Type 1 Diabetes

Who this might be right for
Type 1 Diabetes Mellitus
Montefiore Medical Center 18
Post-approval studies (Phase 4)Study completedNCT00795600
What this trial is testing

Comparison of the Change in Fat Distribution in Overweight and Obese Subjects With Type 2 Diabetes After Insulin Treatment

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 60
Early research (Phase 1)Study completedNCT01159353
What this trial is testing

Pharmacodynamic and Pharmacokinetic Effects of Insulin Glulisine in Obese Subjects With Type 2 Diabetes After a Standard Meal in Comparison to Insulin Aspart

Who this might be right for
Type 2 Diabetes Mellitus
Sanofi 37
Post-approval studies (Phase 4)Ended earlyNCT01333514
What this trial is testing

Carbohydrate Consumption as a Factor in Aspart Dosing

Who this might be right for
Diabetes
Rush University Medical Center 14
Large-scale testing (Phase 3)Study completedNCT00097084
What this trial is testing

Comparison of Insulin Detemir Plus Insulin Aspart Against Insulin Glargine Plus Insulin Aspart in Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 324
Not applicableStudy completedNCT00671008
What this trial is testing

Observational Study of Patients Using NovoMix® 30 or Levemir® for Treatment of Type 1 or Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Novo Nordisk A/S 400
Post-approval studies (Phase 4)Study completedNCT01618214
What this trial is testing

Comparison of Subject-driven Titration of Biphasic Insulin Aspart (BIAsp) 30 Twice Daily Versus Investigator-driven Titration of BIAsp 30 Twice Daily Both in Combination With Oral Antidiabetic Drugs in Subjects With Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 344
Post-approval studies (Phase 4)Study completedNCT01068652
What this trial is testing

Effect of Different Insulin Administrations, All in Combination With Metformin, on Glycaemic Control in Subjects With Type 2 Diabetes Inadequately Controlled by Oral Anti-diabetic Drugs

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 403
Not applicableStudy completedNCT04184492
What this trial is testing

Compare Pharmacokinetics and Pharmacodynamics of GP-40081 to NovoMix® 30 Penfill® in Healthy Subjects

Who this might be right for
Clamp Study
Geropharm 34
Post-approval studies (Phase 4)Study completedNCT00607087
What this trial is testing

Effect of Insulin Glulisine Compared to Insulin Aspart and Insulin Lispro When Administered by Continuous Subcutaneous Insulin Infusion (CSII) on Specific Pump Parameters in Patient With Type 1 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 1
Sanofi 289
Early research (Phase 1)Study completedNCT01524809
What this trial is testing

Pharmacokinetics of Biphasic Insulin Aspart 30 and 70 in Subjects With Type 1 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 1
Novo Nordisk A/S 26
Large-scale testing (Phase 3)Ended earlyNCT00472953
What this trial is testing

Safety of Inhaled Human Insulin in Subjects With Diabetes Mellitus and Chronic Obstructive Pulmonary Disease (COPD)

Who this might be right for
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2+1 more
Novo Nordisk A/S 38
Early research (Phase 1)Study completedNCT01527565
What this trial is testing

Bioequivalence of Two Formulations of Biphasic Insulin Aspart 70 in Healthy Male Subjects

Who this might be right for
DiabetesHealthy
Novo Nordisk A/S 30
Post-approval studies (Phase 4)Study completedNCT01487798
What this trial is testing

Frequency of Episodes of Hypoglycaemia During Treatment With Biphasic Insulin Aspart 30 in Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 170
Large-scale testing (Phase 3)Study completedNCT01486940
What this trial is testing

Comparison of Insulin Detemir Plus Insulin Aspart With Insulin NPH Plus Human Soluble Insulin in Subjects With Type 1 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 1
Novo Nordisk A/S 598
Post-approval studies (Phase 4)Study completedNCT00095446
What this trial is testing

NovoLog Observation Trial in Subjects With Type 1 and Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Novo Nordisk A/S 513
Large-scale testing (Phase 3)Study completedNCT00082407
What this trial is testing

Exenatide Compared With Twice-Daily Biphasic Insulin Aspart in Patients With Type 2 Diabetes Using Sulfonylurea and Metformin

Who this might be right for
Diabetes Mellitus, Type 2
AstraZeneca 505
Not applicableStudy completedNCT00775736
What this trial is testing

Observational Study Evaluating the Safety of NovoMix® in Type 2 Diabetes Patients Previously Treated With a Human Premix Insulin

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 611
Next Page